EPHA7
Summary: This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Increased expression of this gene is associated with multiple forms of carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
EPH receptor A7 | MIM:602190 | Ensembl:ENSG00000135333 | HGNC:HGNC:3390 | PA27822 | 6q16.1 |
GO terms in EPHA7
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IBA | GO:0004709 | MAP kinase kinase kinase activity |
MF | IBA | GO:0004713 | protein tyrosine kinase activity |
MF | ISS | GO:0004713 | protein tyrosine kinase activity |
MF | IBA | GO:0004714 | transmembrane receptor protein tyrosine kinase activity |
MF | IBA | GO:0004888 | transmembrane signaling receptor activity |
MF | ISS | GO:0005004 | GPI-linked ephrin receptor activity |
MF | IBA | GO:0005005 | transmembrane-ephrin receptor activity |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0005524 | ATP binding |
MF | ISS | GO:0008046 | axon guidance receptor activity |
MF | IBA | GO:0031434 | mitogen-activated protein kinase kinase binding |
MF | ISS | GO:0045499 | chemorepellent activity |
MF | IEA | GO:0046875 | ephrin receptor binding |
BP | IEA | GO:0001934 | positive regulation of protein phosphorylation |
BP | IEA | GO:0006915 | apoptotic process |
BP | IBA | GO:0007275 | multicellular organism development |
BP | ISS | GO:0007420 | brain development |
BP | IBA | GO:0009968 | negative regulation of signal transduction |
BP | ISS | GO:0016310 | phosphorylation |
BP | IEA | GO:0018108 | peptidyl-tyrosine phosphorylation |
BP | ISS | GO:0022407 | regulation of cell-cell adhesion |
BP | IBA | GO:0030154 | cell differentiation |
BP | IEA | GO:0031290 | retinal ganglion cell axon guidance |
BP | ISS | GO:0031952 | regulation of protein autophosphorylation |
BP | IBA | GO:0033674 | positive regulation of kinase activity |
BP | IBA | GO:0043066 | negative regulation of apoptotic process |
BP | ISS | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
BP | IBA | GO:0043410 | positive regulation of MAPK cascade |
BP | ISS | GO:0043525 | positive regulation of neuron apoptotic process |
BP | IDA | GO:0048013 | ephrin receptor signaling pathway |
BP | TAS | GO:0048013 | ephrin receptor signaling pathway |
BP | IEA | GO:0048671 | negative regulation of collateral sprouting |
BP | ISS | GO:0048755 | branching morphogenesis of a nerve |
BP | IDA | GO:0050730 | regulation of peptidyl-tyrosine phosphorylation |
BP | ISS | GO:0050919 | negative chemotaxis |
BP | IEA | GO:0051964 | negative regulation of synapse assembly |
BP | IDA | GO:0070372 | regulation of ERK1 and ERK2 cascade |
BP | IBA | GO:0070374 | positive regulation of ERK1 and ERK2 cascade |
BP | IEA | GO:0072178 | nephric duct morphogenesis |
CC | IBA | GO:0005737 | cytoplasm |
CC | TAS | GO:0005886 | plasma membrane |
CC | IBA | GO:0005887 | integral component of plasma membrane |
CC | IEA | GO:0005887 | integral component of plasma membrane |
CC | IEA | GO:0030425 | dendrite |
CC | IEA | GO:0031594 | neuromuscular junction |
CC | IBA | GO:0043005 | neuron projection |
CC | IEA | GO:0043025 | neuronal cell body |
CC | IBA | GO:0043235 | receptor complex |
CC | IEA | GO:0045211 | postsynaptic membrane |
Gene expression in normal tissue: EPHA7
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in EPHA7
Database | Pathway ID | Pathway Des. |
---|---|---|
pid | epha_fwdpathway | EPHA forward signaling |
kegg | hsa04360 | Axon guidance - Homo sapiens (human) |
reactome | R-HSA-1266738 | Developmental Biology |
reactome | R-HSA-1266738 | Developmental Biology |
reactome | R-HSA-2682334 | EPH-Ephrin signaling |
reactome | R-HSA-2682334 | EPH-Ephrin signaling |
reactome | R-HSA-3928663 | EPHA-mediated growth cone collapse |
reactome | R-HSA-3928663 | EPHA-mediated growth cone collapse |
reactome | R-HSA-3928665 | EPH-ephrin mediated repulsion of cells |
reactome | R-HSA-3928665 | EPH-ephrin mediated repulsion of cells |
reactome | R-HSA-422475 | Axon guidance |
reactome | R-HSA-422475 | Axon guidance |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD599 | Salermide | 1 |
iGMDRD76 | Simvastatin | 3 |
iGMDRD126 | Tipifarnib | 4 |
iGMDRD433 | Lexibulin | 1 |
iGMDRD781 | Sirolimus | 2 |
iGMDRD670 | ML 210 | 2 |
iGMDRD144 | NSC95397 | 6 |
iGMDRD427 | ABT737 | 3 |
iGMDRD61 | Kinetin riboside | 7 |
iGMDRD152 | 179324-69-7 | 6 |
iGMDRD446 | LY 2183240 | 2 |
iGMDRD280 | CYTOCHALASIN B | 2 |
iGMDRD679 | Bistramide A | 1 |
iGMDRD474 | Avrainvillamide | 4 |
iGMDRD138 | PX 12 | 5 |
iGMDRD318 | PAC-1 | 5 |
iGMDRD52 | Rotenone | 4 |
iGMDRD187 | BRD9876 | 1 |
iGMDRD870 | BRD63610 | 4 |
iGMDRD782 | DC-45-A2 | 2 |
iGMDRD506 | Fedratinib | 2 |
iGMDRD562 | Navitoclax | 5 |
iGMDRD188 | Piperlongumine | 2 |
iGMDRD100 | Zebularine | 2 |
iGMDRD74 | Idarubicin | 3 |
iGMDRD451 | Serdemetan | 2 |
iGMDRD60 | Quinoclamine | 2 |
iGMDRD84 | Lovastatin acid | 3 |
iGMDRD486 | Tosedostat | 3 |
iGMDRD330 | BRD4132 | 2 |
iGMDRD79 | Gemcitabine | 5 |
iGMDRD560 | MK-2206 | 2 |
iGMDRD116 | CD437 | 1 |
iGMDRD57 | Chloropentafluorobenzene | 3 |
iGMDRD698 | Neratinib | 4 |
iGMDRD85 | Ursolic acid | 4 |
iGMDRD945 | ML214 | 3 |
iGMDRD211 | (1S,3R)-RSL3 | 3 |
iGMDRD177 | Teniposide | 2 |
iGMDRD5 | Tyrphostin AG 1478 | 4 |
iGMDRD103 | SN-38 | 2 |
iGMDRD137 | Indisulam | 4 |
iGMDRD251 | ML162 | 4 |
iGMDRD121 | GMX1778 | 7 |
iGMDRD202 | Curcumin | 3 |
iGMDRD158 | NSC141540 | 2 |
iGMDRD289 | Parthenolide | 5 |
iGMDRD329 | Merck60 | 3 |
iGMDRD366 | PI-103 | 2 |
iGMDRD871 | BRD6368 | 3 |
iGMDRD414 | MST-312 | 2 |
iGMDRD872 | BRD7137 | 3 |
iGMDRD42 | Vorinostat | 3 |
iGMDRD322 | FK 866 | 1 |
iGMDRD505 | Pevonedistat | 3 |
iGMDRD263 | AACOCF3 | 5 |
iGMDRD552 | AZD-1775 | 5 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in EPHA7